Literature DB >> 8046406

Expression of equine herpesvirus type 1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses.

N Osterrieder1, R Wagner, M Pfeffer, O R Kaaden.   

Abstract

The extracellular portion (amino acids 1 to 844) of the equine herpesvirus type 1 (EHV-1) glycoprotein gp14, the homologue of gB of herpes simplex virus, was expressed in Escherichia coli and in insect cells using a recombinant baculovirus. Immunoblot analysis revealed that the recombinant E. coli expressed a fusion protein of M(r) 135K which was composed of the truncated gp14 and the maltose-binding protein (MBP) provided by the vector and a 90K protein lacking the MBP moiety. Both proteins were sequestered within the cells in form of inclusion bodies. Infection of insect cells with the recombinant baculovirus resulted in the production of a 115K to 118K glycoprotein which was cleaved intracellularly into two subunits of M(r) 55K and 63K to 65K. The cleaved subunits were secreted into the cell culture supernatant and formed disulphide-linked dimers of M(r) 120K to 122K. The recombinant proteins produced in E. coli and in insect cells elicited EHV-1-specific antibodies in goats as demonstrated by Western blot analysis. The gp14 expressed in insect cells induced antibodies with virus-neutralizing activity. In contrast, the truncated gp14 expressed by E. coli failed to elicit neutralizing antibodies. The results suggest that post-translational modification of the EHV-1 gp14 may be important for the expression of epitopes necessary for the induction of neutralizing antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046406     DOI: 10.1099/0022-1317-75-8-2041

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

1.  A single plasmid transfection that offers a significant advantage associated with puromycin selection in Drosophila Schneider S2 cells expressing heterologous proteins.

Authors:  Takayuki Iwaki; Francis J Castellino
Journal:  Cytotechnology       Date:  2008-02-08       Impact factor: 2.058

2.  Immunization with Attenuated Equine Herpesvirus 1 Strain KyA Induces Innate Immune Responses That Protect Mice from Lethal Challenge.

Authors:  Seong K Kim; Akhalesh K Shakya; Dennis J O'Callaghan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

Review 3.  Insect cells as hosts for the expression of recombinant glycoproteins.

Authors:  F Altmann; E Staudacher; I B Wilson; L März
Journal:  Glycoconj J       Date:  1999-02       Impact factor: 2.916

4.  Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice.

Authors:  P M Smith; Y Zhang; S R Jennings; D J O'Callaghan
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model.

Authors:  D Tewari; S V Nair; M C De Ungria; G L Lawrence; M Hayden; D N Love; H J Field; J M Whalley
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

Review 6.  Recombinant viral proteins for use in diagnostic ELISAs to detect virus infection.

Authors:  Kelly-Anne Spencer; Fernando A Osorio; Julian A Hiscox
Journal:  Vaccine       Date:  2007-03-06       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.